SCHEMBL4780581

SCHEMBL4780581

COc1ccccc1C(=O)c1ncc(Cl)cc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 8/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
CCR4 P51679 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CCR5 P51681 1/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
KDM4E B2RXH2 1/20 0.53
HSD17B10 Q99714 1/20 0.53
ALDH1A1 P00352 1/20 0.49
NPSR1 Q6W5P4 2/20 0.46
ALOX12 P18054 1/20 0.46
CCR1 P32246 1/20 0.46
CCR9 P51686 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10223387 0.95 CCR2 (0.54) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL12594756 0.91 CCR2 (0.51) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL10223665 0.90 CCR9 (0.56) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL306793 0.90 CCR2 (0.67) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL29888412 0.90 CCR2 (0.67) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL10223328 0.88 CCR2 (0.57) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL10223329 0.88 MEN1 (0.52) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL10223391 0.87 CCR2 (0.56) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL305031 0.85 CYP2C9 (0.60) CCR2CYP3A4CYP2C9CYP2C19CCR4
SCHEMBL10223235 0.84 CCR2 (0.56) CCR2CYP3A4CYP2C9CYP2C19CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008008431-A2 HETEROARYL SULFONAMIDES AND CCR2/CCR9 CHEMOCENTRYX, INC. (US) 2008-01-17 WO disclosed